Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Operationalising Multifactorial Ovarian Cancer Risk Assessment Using the CanRisk Tool Versus Standard Practices.

NCT07809659 is registered in ClinicalTrials.gov with Instituto Portugues Oncologia de Lisboa Francisco Gentil as lead sponsor.

NCT NCT07809659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07809659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Operationalising Multifactorial Ovarian Cancer Risk Assessment Using the CanRisk Tool Versus Standard Practices.
Lead sponsor
Instituto Portugues Oncologia de Lisboa Francisco Gentil
Phase
Not applicable
Overall status
Recruiting
Start date
August 6, 2026
Completion date
September 30, 2028
Enrollment
2,130 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer